These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1420824)

  • 21. Massive pulmonary embolism with cardiac arrest treated with continuous thrombolysis and concomitant hypothermia.
    Hovland A; Bjørnstad H; Hallstensen RF; Hugaas KA; Westlie JA; Elden T; Andersen K
    Emerg Med J; 2008 May; 25(5):310-1. PubMed ID: 18434480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tissue plasminogen activator (alteplase) in acute massive pulmonary embolism. A pilot study].
    Lang M; Charbonnier B; Quilliet L; Pacouret G; Poitrineau O; Mannara R; Neel G; Desveaux B; Raynaud P; Brochier ML
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1803-11. PubMed ID: 2514632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic thrombolysis for acute pulmonary embolism.
    Bartel B
    Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
    Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial.
    Sors H; Pacouret G; Azarian R; Meyer G; Charbonnier B; Simonneau G
    Chest; 1994 Sep; 106(3):712-7. PubMed ID: 8082346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Massive pulmonary embolism treated with a reduced dose of alteplase in a patient with acute renal failure].
    Elikowski W; Małek M; Bar-Letkiewicz I; Kawczyński S; Predki R
    Kardiol Pol; 2008 Aug; 66(8):885-8; discussion 888. PubMed ID: 18803142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism].
    Peng K; Wang C; Pang BS; Yang YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Sep; 28(9):596-9. PubMed ID: 16207425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Massive pulmonary embolism during the third trimester of pregnancy: effectiveness of thrombolytic treatment with alteplase].
    Saviotti M; Bongarzoni A; Casazza F
    G Ital Cardiol; 1997 Jan; 27(1):72-5. PubMed ID: 9244713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desmoteplase in acute massive pulmonary thromboembolism.
    Tebbe U; Bramlage P; Graf A; Lechleitner P; Bode C; Riess FC; Clemens N; Al-Rawi Y; Konstantinides S; Goldhaber SZ
    Thromb Haemost; 2009 Mar; 101(3):557-62. PubMed ID: 19277420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
    Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
    Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.
    Tanswell P; Tebbe U; Neuhaus KL; Gläsle-Schwarz L; Wojcik J; Seifried E
    J Am Coll Cardiol; 1992 Apr; 19(5):1071-5. PubMed ID: 1372625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of alteplase thrombolysis for ED treatment of pulmonary embolism with shock.
    Le Conte P; Huchet L; Trewick D; Longo C; Vial I; Batard E; Yatim D; Touzé MD; Baron D
    Am J Emerg Med; 2003 Sep; 21(5):438-40. PubMed ID: 14523886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activator.
    Nelles L; Li XK; Vanlinthout I; De Cock F; Lijnen HR; Collen D
    Thromb Haemost; 1992 Apr; 67(4):445-52. PubMed ID: 1631793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism.
    Madani H; Ransom PA
    Emerg Med J; 2007 Jun; 24(6):441. PubMed ID: 17513552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
    de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.